Newly dignosised type 2 diabetes according to WHO criteria.glycated hemoglobin (HbA1c) was more than 10%;
Seronegative for antibodies against insulin, islet cells and glutamic acid decarboxylase (GAD);

NCT02535299_inc_T1
Temporal
Newly dignosised
NCT02535299_inc_T2
Condition
type 2 diabetes
NCT02535299_inc_T3
Qualifier
WHO criteria
NCT02535299_inc_T4
Measurement
glycated hemoglobin (HbA1c)
NCT02535299_inc_T5
Value
more than 10%
NCT02535299_inc_T6
Negation
Seronegative
NCT02535299_inc_T7
Condition
antibodies
NCT02535299_inc_T8
Qualifier
insulin
NCT02535299_inc_T9
Qualifier
islet cells
NCT02535299_inc_T10
Qualifier
glutamic acid decarboxylase (GAD)
NCT02535299_inc_T11
Scope
insulin, islet cells and glutamic acid decarboxylase (GAD)